Related by context. All words. (Click for frequent words.) 68 liver histology 67 Negative Syndrome 67 lumbar spine BMD 67 SSRI SNRI 66 YMRS 66 p = .# [002] 65 adjunctive placebo 65 Rating Scale MADRS 65 oxycodone CR 65 % Confidence Interval 65 HBeAg seroconversion 65 PANSS total 65 MADRS score 65 posttreatment 65 HbA 1c levels 64 RLAI 64 tolterodine ER 64 IBDQ 64 PANSS 64 P = .# 64 MADRS 64 HAQ DI 64 HDRS 64 UPDRS motor 64 HbA 1c 64 CI -#.# 64 divalproex sodium 64 MMSE scores 64 desvenlafaxine succinate 64 -#.# mg dL [002] 64 PASI scores 64 GERD symptom 64 subscale scores 64 Brief Psychiatric 63 achieved ACR# 63 CR nPR 63 depressive symptom 63 SGRQ 63 clinically meaningful improvement 63 WOMAC pain 63 Montgomery Åsberg Depression 63 Scale PANSS 63 ziprasidone 63 certolizumab 63 Montgomery Asberg Depression 63 extrapyramidal symptoms 63 p = NS 63 alanine aminotransferase 63 elevated ALT 63 rimonabant #mg 63 #.#/#.# mmHg [001] 63 MMSE score 63 EDSS scores 63 ADAS cog 62 solifenacin 62 ADAS Cog 62 nonsignificant difference 62 amisulpride 62 mcg BID 62 methotrexate monotherapy 62 8mg/kg 62 serum cortisol 62 HOMA IR 62 baseline HbA1c 62 HBeAg negative patients 62 placebo p = 62 4mg/kg 62 #mg/day [001] 62 mg TID 62 alanine aminotransferase ALT 62 Pred Forte 62 undetectable HBV DNA 62 6MWD 62 hip BMD 62 titrated glipizide 62 NYHA functional class 62 -#.# mg dL [001] 62 Neuropsychiatric Inventory 62 serum urate levels 62 attain statistical significance 61 achieved statistical significance 61 prolactin elevation 61 insulin detemir 61 corticosteroid dose 61 HRQL 61 urinary N telopeptide 61 UPDRS 61 Platelet counts 61 serum testosterone 61 ADCS CGIC 61 pulmonary capillary wedge 61 BMI z 61 psychosocial functioning 61 glycosylated hemoglobin levels 61 symptom severity 61 intact parathyroid hormone 61 #mg/day [002] 61 tapentadol ER 61 neurocognitive function 61 μmol L 61 SGPT 61 clomipramine 61 hepatic enzymes 61 Negative Symptoms 61 Crohn Disease Activity 61 abacavir lamivudine 61 serum urate 61 lowest tertile 61 Partial Response 61 salmeterol fluticasone 61 FDA defined valvulopathy 61 tiotropium 61 plasma homocysteine 61 tolterodine 61 atazanavir ritonavir 61 mg BID dose 61 virologic response 61 CPAP adherence 61 plus methotrexate 61 Y BOCS 61 Flu Cy 61 lopinavir r arm 61 HbA1C levels 61 posttest 61 HAM D# 61 venlafaxine XR 61 moderate renal impairment 60 NPH insulin 60 serum potassium 60 hematologic parameters 60 Serum creatinine 60 tipranavir r 60 fasting plasma glucose FPG 60 β blocker 60 Index CDAI 60 % CI #.#-#.# [007] 60 -#.# ± [002] 60 NIH CPSI 60 guanfacine extended release 60 QIDS SR 60 achieved CCyR 60 mcg QD 60 fluticasone salmeterol 60 ACTEMRA TM 60 affective psychosis 60 lamivudine refractory patients 60 HRQOL 60 aminotransferases 60 univariate analyzes 60 echocardiographic parameters 60 #mg dose [002] 60 Symptom severity 60 ADCS ADL 60 plasma leptin 60 plasma cortisol 60 SGOT 60 protein excretion 60 umol L 60 lumbar spine bone 60 serum bicarbonate 60 comparator arm 60 Fasting plasma glucose 60 posttransplant 60 Ishak fibrosis score 60 complete cytogenetic response 60 elevated creatinine 60 % CI #.#-#.# [003] 60 virological response 60 dapagliflozin plus 60 bosentan 60 erection hardness 60 Score DAS# 60 International Prostate Symptom 60 neuroleptic 60 postintervention 60 CANCIDAS 60 nasal symptom 60 hsCRP levels 60 mesalamine granules 60 serum phosphate levels 60 ADHD RS 60 hypomagnesemia 60 AUC0 60 â ‰ ¥ 60 Lucentis monotherapy 60 adjunctive ABILIFY 59 mRS 59 aspartate aminotransferase 59 NNT = 59 adenoma recurrence 59 tapentadol IR 59 Global Impression 59 ADHD Rating Scale 59 anemia hemoglobin 59 odds ratios ORs 59 salivary cortisol 59 severe exacerbations 59 Alzheimer Disease Assessment 59 opioid naïve 59 interrater reliability 59 SSRI citalopram 59 hemoglobin A1c levels 59 ATACAND 59 % CI #.#-#.# [008] 59 sUA 59 euthymic patients 59 plasma pharmacokinetics 59 NATRECOR R 59 HbA1c levels 59 lispro 59 genotypic resistance 59 tegaserod 59 placebo p 59 transaminase elevations 59 confidence intervals CIs 59 interquartile range 59 ULORIC 59 BPRS 59 baseline serum creatinine 59 CrCl 59 agomelatine 59 nighttime awakenings 59 Visual acuity 59 pentoxifylline 59 HBeAg 59 budesonide pMDI 59 mitoxantrone plus 59 statistically significant p = 59 clinically meaningful improvements 59 EDARBI 59 TNSS 59 quetiapine 59 NIHSS 59 serum ALT 59 mg p = 59 MoxDuo TM IR 59 subscore 59 oxcarbazepine 59 creatinine ratio 59 receiving golimumab 59 Danazol 59 comorbid depression 59 CDAI score 59 atorvastatin #mg 59 paroxetine sertraline 59 hemoglobin A1c HbA1c 59 platelet reactivity 59 timepoints 59 subscales 59 glycemia 59 serum creatinine levels 59 Psoriasis Area 59 lipid parameters 59 serum uric acid 59 Median PFS 59 alteplase 59 lopinavir r 59 AST ALT 59 ug kg 59 tolvaptan 59 p = #.# [002] 59 mg kg dose 59 Hb A1C 59 H2RAs 59 serum lipid levels 59 mmol l 59 mucosal healing 59 lipid profiles 59 mg eq 59 INVEGA ® 59 ACEIs 59 multivariable adjusted 59 aspirin NSAIDs 59 Visual Analog Scale 59 #mg doses [002] 59 relapsed MM 59 racemic albuterol 59 CCyR 59 APTIVUS r 59 Primary endpoints 59 plus OBT 59 serum folate 59 T2 lesion volume 59 hematological parameters 59 mg BID 59 HbA1C 59 AUA Symptom Score 59 = #.#-#.# 59 Pain Intensity 59 % CI #.#-#.# [006] 59 overt nephropathy 59 TMC# r 59 mg QD 59 mL/min/#.# m 2 59 dose dependently 59 Postoperative 58 REYATAZ r arm 58 EXJADE 58 DAS# remission 58 5-FU/LV 58 adalimumab 58 MADRS scores 58 nicardipine 58 clodronate 58 inotropic 58 octreotide LAR 58 serum homocysteine 58 Secondary endpoints included 58 maximal doses 58 DAS# scores 58 KRAS mutant tumors 58 PSA nadir 58 CIMZIA ™ 58 incidence ≥ 58 dexmedetomidine 58 chlorambucil 58 glomerular filtration 58 serum testosterone levels 58 IPSS 58 symptomatic intracerebral hemorrhage 58 P ≤ 58 NIHSS score 58 annualized relapse 58 daytime somnolence 58 μg d 58 dalteparin 58 transaminases 58 tHcy 58 confidence interval CI 58 systolic BP 58 infliximab monotherapy 58 nondiabetic patients 58 p = .# [001] 58 mmHg diastolic 58 cardiovascular calcification 58 plasma creatinine 58 Postoperatively 58 primary aldosteronism 58 paliperidone ER 58 systemic corticosteroid 58 symptomatic VTE 58 peak VO2 58 aspartate aminotransferase AST 58 sotalol 58 flutamide 58 SVR# 58 Unified Parkinson Disease 58 AGILECT ® 58 tranylcypromine 58 antioxidant supplementation 58 vasopressor 58 ALT AST 58 mild renal insufficiency 58 p = #.# [003] 58 acute bipolar mania 58 prednisone prednisolone plus 58 serum estradiol 58 systolic function 58 prazosin 58 plasma folate 58 biochemical recurrence 58 somatostatin analog 58 fosamprenavir 58 undetectable viral 58 sustained virological response 58 alfuzosin 58 mg simvastatin 58 QTcF 58 hypophosphatemia 58 CIMZIA TM certolizumab pegol 58 glycated hemoglobin HbA1c 58 PREZISTA r arm 58 ALISTA 58 #.#mg/dL 58 dyspnea 58 ratio ICER 58 DLQI 58 Depressive symptoms 58 placebo controlled clinical trials 58 euthymic 58 placebo dexamethasone 58 mmHg p = 58 intima media thickness 58 hypokalemia 58 ritonavir boosted 58 β blockers 58 receiving ISENTRESS 58 HBeAg + 58 Subgroup analysis 58 QTc 58 emotional lability 58 daytime alertness 58 SCr 58 N telopeptide 58 multivariable analysis 58 leukocyte counts 58 symptom exacerbation 58 FOLFOX4 58 antidepressant efficacy 58 pulmonary exacerbations 58 mg ustekinumab 58 μg kg 58 cardiac autonomic 58 Secondary endpoints include 58 aripiprazole 58 CDAI 58 #OHD 58 plus prednisone 58 Scale EDSS score 58 PREZISTA ritonavir 58 pCR 58 AGILECT R 58 paricalcitol 58 3mg/kg 58 Scale cognitive subscale 58 hepatic insulin sensitivity 58 perioperatively 58 Secondary endpoints 58 CD# upregulation 58 p = #.# [004] 58 HRQoL 58 trough FEV1 58 placebo fluoxetine 57 serum magnesium 57 somatic symptom 57 WOMAC scores 57 serum phosphate 57 glycosylated hemoglobin HbA1c 57 receiving VICTRELIS 57 -#.# log# 57 TPV r 57 detemir 57 ALT flares 57 Demonstrated Significant 57 depressive symptomatology 57 maximal tolerated 57 tHcy concentrations 57 serum sodium 57 confidence interval #.#-#.# 57 parkinsonian symptoms 57 serum ferritin 57 serum phosphorus 57 prospectively defined 57 unresectable HCC 57 EDSS score 57 concomitant medications 57 metabolic parameters 57 IFN beta 57 Pharmacokinetic parameters 57 prospectively stratified 57 HBeAg positive 57 #mg BID [003] 57 CR CRu 57 neutrophil counts 57 ALT elevation 57 serum BDNF 57 poststroke 57 Health Assessment Questionnaire 57 oral prednisolone 57 #μg [002] 57 LATUDA 57 FOLPI 57 univariate analysis 57 subscores 57 prolactin levels 57 haematologic 57 ropivacaine 57 urodynamic parameters 57 CIMZIA TM 57 Cmax 57 doxazosin 57 XEPLION R 57 apolipoprotein B 57 mg Pycnogenol 57 tirofiban 57 irbesartan 57 experienced virologic failure 57 serum phosphorous 57 hepatic enzyme 57 IV bisphosphonates 57 PCWP 57 postdose 57 aminotransferase elevations greater 57 serum sodium levels 57 neurologic progression 57 glycated hemoglobin 57 Score IPSS 57 achieved PASI 57 Insulin sensitivity 57 mg/m2 dose 57 salivary flow 57 preintervention 57 urge urinary incontinence 57 acarbose 57 #.#/#.# mm Hg [003] 57 TDF FTC 57 oral diclofenac 57 serum IGF 57 PSADT 57 diarrhea flatulence 57 atrioventricular block 57 serum CRP 57 nonfatal MI 57 carotid IMT 57 NAbs 57 QD dosing 57 corrected QT interval 57 interferon ribavirin 57 ejaculatory function 57 serum leptin 57 Dyspnea 57 CsA 57 blood Phe levels 57 prodromal symptoms 57 mg XP# 57 mg RDEA# 57 concomitant AEDs 57 linaclotide treated 57 incontinence episodes 57 femoral neck BMD 57 Visual Analogue Scale VAS 57 fasting insulin 57 pegylated IFN 57 hours postdose 57 APACHE II 57 comorbid anxiety 57 DAS# CRP 57 isoproterenol 57 TLUS 57 creatinine levels 57 IOP lowering 57 Vildagliptin 57 creatinine clearance 57 ibandronate 57 mEq L 57 serum calcium levels 57 extracellular dopamine 57 bezafibrate 57 oral levofloxacin 57 baseline A1C 57 dyspareunia 57 Secondary efficacy endpoints 57 TURBT 57 QoL 57 #mg BID [001] 57 plus MTX 57 antiandrogen 57 morphometric vertebral fractures 57 BENICAR HCT 57 Inventory BPI 57 lymphopenia 57 statistical significance p 57 albumin excretion rate 57 BPH symptom 57 PSQI 57 atheroma volume 57 mg tid 57 mg d 57 pooled comparator 57 HBeAg positive patients 57 antiretroviral naive 57 Severity Index PASI 57 prucalopride 57 Univariate analysis 57 CYP#D# inhibitor 57 clinically meaningful reductions 57 urinary cortisol 57 chlorthalidone 57 fasting plasma 57 baseline PASI 57 binary restenosis 57 ETDRS 57 recurrent venous thromboembolism 57 pramipexole 57 serum concentrations 57 lupus anticoagulant 57 hepatic function 57 demonstrated clinically meaningful 56 aldosterone antagonists 56 MCyR 56 thyrotropin levels 56 microbiological eradication 56 #mg dose [001] 56 Expanded Disability Status 56 conventional DMARDs 56 fructosamine 56 serum folate concentrations 56 oral antidiabetes 56 albumin excretion 56 IR prednisone 56 Double Blind Randomized 56 eszopiclone 56 molindone 56 hemoglobin A1C 56 analgesic medications 56 biopsy Gleason 56 IFN α 56 LEXIVA r 56 mTSS 56 lactate dehydrogenase 56 VaD 56 elevated serum creatinine 56 indinavir 56 macroalbuminuria 56 postprocedure 56 CNS LS 56 ALIMTA cisplatin 56 highly emetogenic 56 FOLFIRI alone 56 PegIFN RBV 56 zoledronate 56 salmeterol fluticasone propionate 56 IRLS score 56 eplerenone 56 mucosal inflammation 56 postop 56 beta blocker therapy 56 HER2 expression 56 HIV uninfected 56 adefovir treated 56 amoxicillin clavulanate 56 beta 1a 56 x ULN 56 TMP SMX 56 urinary albumin 56 plasma triglycerides 56 budesonide formoterol 56 steroid dexamethasone 56 preoperatively 56 T2DM 56 fluoxetine paroxetine 56 biphasic insulin aspart 56 acromegalic patients 56 COPD exacerbation 56 psychiatric comorbidity 56 nmol l 56 ACR# ACR# 56 Scale EDSS 56 caspofungin 56 statin monotherapy 56 spontaneous bowel movements 56 exploratory endpoints 56 oral antidiabetic medication 56 urinary oxalate 56 sitaxsentan 56 postoperative complication 56 Fasting blood glucose 56 Celsentri Selzentry 56 Score DAS 56 HbA 1C 56 SBM frequency 56 non menstrual pelvic 56 serum triglyceride levels 56 Zometa hazard 56 triglyceride concentrations 56 Global Impression CGI 56 plasma renin activity 56 androgen suppression 56 median PFS 56 virological suppression 56 balsalazide 56 sustained virologic response 56 Lantus ® 56 Apidra ® 56 darunavir ritonavir 56 hypocalcemia 56 HIV RNA 56 AUA BPH Symptom Score 56 BARACLUDE ® 56 chemoradiation therapy 56 ezetimibe simvastatin 56 aminotransferase levels 56 biochemical relapse 56 paraprotein 56 plasma glucose 56 elevated uric acid 56 transaminase levels 56 liver transaminases 56 serum lipid 56 extrapyramidal side 56 #μg [001] 56 rizatriptan 56 multivariate adjustment 56 ALT elevations 56 unfractionated heparin UFH 56 Natalizumab 56 placebo PBO 56 pyridostigmine 56 IFN alfa 56 #q# deletion syndrome 56 conventional antipsychotics 56 serologically active patients 56 symptomatology 56 antihypertensive therapy 56 antibody titer 56 UPDRS scores 56 isoprostane 56 uM 56 dysuria 56 metformin monotherapy 56 placebo 56 fatigue asthenia 56 glycated hemoglobin levels 56 FOSRENOL ® 56 serum aminotransferase levels 56 Rating Scale BPRS 56 Mg Uk 56 laxation 56 ACR# response 56 mg Proellex 56 lymphocytosis 56 micafungin 56 OGTT 56 g dl 56 ‰ ¥ 56 + PH# 56 headache abdominal pain 56 gm dl 56 serum calcium 56 virologic failure 56 Abilify aripiprazole 56 dose atorvastatin 56 constipation dizziness 56 hematologic toxicity 56 hemoglobin Hb 56 Main Outcome Measures 56 triacylglycerol concentrations 56 eculizumab therapy 56 MIRAPEX 56 comorbid 56 pT3 56 serum PTH 56 urinary excretion 56 leukopenia 56 low dose Iluvien 56 inotropic agents 56 mmHg systolic 56 QTc intervals 56 somnolence sleepiness 56 pretreatment baseline 56 titration phase 56 calcium antagonist 56 preoperative PSA 56 cerebral oxygenation 56 moderate hepatic impairment 56 arterial thromboembolic events 56 deep venous thromboses 56 fasting plasma glucose 56 affective disorders 56 #ug [001] 56 dose proportionality 56 ARB telmisartan 56 risperidone 56 CI #.#-#.# [002] 56 adrenal function 56 serum HCV RNA 56 Kaplan Meier analysis 56 rhGH 56 progression TTP 56 baseline LDH 56 Relapsing Remitting Multiple Sclerosis 56 pegylated interferon alfa 56 CYP#A# substrate 56 LV ejection fraction 56 CONCERTA ® 56 urate lowering therapy 56 piperacillin tazobactam 56 elevated LDH 56 rHuEPO 56 periprocedural 56 frequent awakenings 56 constipation nausea 56 efavirenz EFV 56 ribavirin therapy 56 isolated systolic hypertension 56 divalproex 56 folinic acid 56 postoperatively 56 peginterferon alfa 2b 56 alanine transaminase 56 postinjury 56 pegaptanib 56 serum HBV DNA 56 methacholine challenge 56 microgram mcg 56 left ventricular diastolic 55 plus medroxyprogesterone acetate 55 1mg 2mg 55 nadolol 55 Generalized Anxiety Disorder 55 specific antigen PSA 55 intravenous cyclophosphamide 55 urinary calcium 55 glycosylated hemoglobin 55 RLS symptoms 55 rFSH 55 sumatriptan naproxen sodium 55 spirometric 55 sulfasalazine 55 bisoprolol 55 Treated Patients 55 mcg doses 55 elevated transaminases 55 haloperidol 55 retinal thickness 55 HADS 55 ritonavir boosted atazanavir 55 Non Responders 55 mitoxantrone 55 oxycodone IR 55 detrusor 55 prednisone prednisolone 55 APTIVUS 55 dehydroepiandrosterone sulfate 55 flow mediated dilation 55 calculated creatinine clearance 55 CI #.#-#.# [001] 55 azathioprine 55 CVD mortality 55 airway hyper responsiveness 55 endometrial thickness 55 Thal Dex 55 highest tertile 55 oral ibandronate 55 triiodothyronine 55 WOMAC TM 55 TEAEs 55 mg hydrochlorothiazide 55 #mmHg [001] 55 quetiapine risperidone 55 pharmacodynamic parameters 55 pamidronate 55 EQ 5D 55 LUTS 55 oral naltrexone 55 Hb A1c 55 intravenous diuretics 55 FROVA 55 systemic hypotension 55 Symptom Score 55 epoprostenol 55 bortezomib refractory 55 saline placebo 55 HAMD 55 galiximab 55 nondepressed 55 headache nasopharyngitis 55 iPTH 55 plus prednisone prednisolone 55 XIENCE V PROMUS Stent 55 nonobese 55 hemodynamic parameters 55 benazepril 55 Capesaris 55 OAB symptoms 55 Acetate Rectal Suppositories 55 mcg albinterferon alfa 2b 55 rabeprazole 55 -#.# mm Hg 55 antidiabetic medication 55 Seroquel quetiapine fumarate 55 lipid lowering agents 55 candesartan cilexetil 55 pharmacokinetic parameters 55 ml kg 55 LPV r 55 zonisamide SR 55 thrombocytopenic 55 Clinically meaningful 55 demonstrated statistically significant 55 induce orthostatic hypotension 55 GI motility 55 RYGB 55 normotensive 55 antiretroviral naïve 55 colorectal adenoma 55 hypoglycaemic episodes 55 tertiles 55 Pharmacokinetic 55 premenopause 55 subcutaneous insulin 55 CORE OM 55 sd = 55 ECOG PS 55 olanzapine 55 lamotrigine 55 venlafaxine Effexor 55 mL kg 55 R# #mg BID 55 doxorubicin cyclophosphamide 55 μg mL 55 somnolence dizziness 55 nasopharyngitis headache 55 aPTT 55 LVEF 55 GPIIb IIIa inhibitors 55 vaginal progesterone gel 55 aspirin clopidogrel 55 shorter telomere length 55 AVODART 55 interferon alfa 2b 55 Ziprasidone 55 KAPIDEX 55 metabolic alkalosis 55 CLA supplementation 55 conjugated equine estrogen 55 non squamous histology 55 QALE 55 somatic symptoms 55 Engerix B 55 virologic suppression 55 Esomeprazole 55 gadobutrol 55 estimated GFR 55 sociodemographic characteristics 55 paresthesias 55 URTI 55 Non inferiority 55 enalapril 55 serum vitamin D 55 Effexor venlafaxine 55 cells uL 55 weekly subcutaneous injections 55 coadministration 55 leukocyte count 55 radiographic progression 55 Suicidal ideation 55 Depressive Symptoms 55 myopathy rhabdomyolysis 55 sham injections 55 plasma viremia 55 VIIBRYD 55 cilostazol 55 neuropathy sensory 55 nadroparin 55 Ocular Surface Disease 55 serum PSA 55 pmol L 55 labetalol 55 dobutamine 55 neuroleptics 55 postoperative mortality 55 oral anticoagulant therapy 55 epoetin alpha 55 leucopenia 55 daunorubicin 55 IRLS 55 apnea hypopnea 55 viral titers 55 vasodilatation 55 LANTUS R 55 PRADAXA #mg 55 Key secondary endpoints 55 mL sec 55 sensory gating 55 p = 55 lanthanum carbonate 55 imipramine 55 coinfected patients 55 vitreous floaters 55 Known hypersensitivity 55 endoscopic remission 55 VADT 55 HMG CoA reductase inhibitors 55 mm Hg diastolic 55 teriflunomide 55 hypogonadal men 55 Kaplan Meier 55 statistically significant p 55 p ≤ 55 adenotonsillectomy 55 p = ns 55 Lamotrigine 55 oral allopurinol 55 ventricular tachyarrhythmia 55 adenoma detection 55 Patients Receiving 55 peginterferon alfa 2a 55 intravascular hemolysis 55 LEXIVA 55 ribavirin RBV 55 Severity MSCS score 55 dose Iluvien 55 #-#,# mg 55 Mania Rating Scale 55 adefovir 55 platelet inhibition 55 inflammatory biomarkers 55 terazosin 55 nitroprusside 55 intima media thickness IMT 55 detectable HCV RNA 55 virologic responses 55 IELT 55 warfarin erythromycin 55 prostaglandin analogues 55 trimethoprim sulfamethoxazole 55 Desvenlafaxine Succinate 55 nonsignificant